WHO ICTRP trial
A multicenter, prospective, randomized controlled clinical study to compare the…
ChiCTR2100045780 · Chinese Clinical Trial Registry (ChiCTR) · Recruiting
Key facts
| Trial ID | ChiCTR2100045780 |
|---|---|
| Public title | A multicenter, prospective, randomized controlled clinical study to compare the efficacy of DAV and DA regimens in the treatment of adult acute myeloid leukemia |
| Scientific title | A multicenter, prospective, randomized controlled clinical study to compare the efficacy of DAV and DA regimens in the treatment of adult acute myeloid leukemia |
| Primary sponsor | The First Affiliated Hospital of Medical College of Zhejiang University |
| Registry | Chinese Clinical Trial Registry (ChiCTR) |
| Recruitment status | Recruiting |
| Study type | Interventional study |
| Phase | 3 |
| Countries | China |
| Conditions | acute myeloid leukemia |
| Interventions | Group A:Daunorubicin 60mg/m2/d, qd, intravenously, d1-d3, cytarabine 100mg/ m2/d, qd, intravenously or subcutaneously, divided twice, separated by 12h, d1-d7, Venecola 100mg d4, 200mg d5, 400mg d6-d11, qd, oral;Group B:Daunorubicin 60mg/… |
| Registration date | Apr 24, 2021 |
| Target size | Group A:32;Group B:32 |
| Registry page | chictr.org.cn |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: